Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1662 | Thyroid (non-cancer) | ICEECE2012

Elastography in the differential diagnosis of thyroid nodules

Cakal E. , Sahin M. , Ozturk Unsal I. , Gungunes A. , Tutal Akkaymak E. , Cakir Ozkaya E. , Colak Bozkurt N. , Ozbek M. , Delibasi T.

Objective: Despite the publication of a recent meta-analysis of elastography in thyroid nodules, further work is necessary on this issue in different populations. In this study we aimed to evaluate the clinical value of elastography in nodular goiter in mild iodine defficient region without excluding according to nodule charecteristics.Materials and methods: This prospective study was conducted between April 2010 and December 2011 in Yildirim Beyazit Dis...

ea0029p1444 | Pituitary Clinical | ICEECE2012

Evaluation of cardiovascular risk factors and metabolic profile in hyperprolactinemic subjects

Sayki Arslan M. , Sahin M. , Esra T. , Cakir Ozkaya E. , Bozkurt Colak N. , Karbek B. , Ozturk Unsal I. , Ucan B. , Gungunes A. , Cakal E. , Ozbek M. , Topaloglu O. , Demirci T. , Karakose M. , Caliskan M. , Ginis Z. , Delibasi T.

Objective: Hyperprolactinemia has been reported to be associated with abnormalities of glucose metabolism and cardiovascular inflammatory markers. However, the metabolic effects of high prolactin levels are not adequately clarified. The aims of this study were to evaluate the effects of hyperprolactinemia on endothelial function, insulin sensitivity and inflammatory markers in prolactinoma diagnosed subjects.Methods: In total, 58 hyperprolactinemic subje...

ea0029p1725 | Thyroid (non-cancer) | ICEECE2012

Serum nesfatin-1 levels in overt and subclinical hyperthyroidism

Gungunes A. , Ginis Z. , Demirci T. , Cakir E. , Karbek B. , Sayki Arslan M. , Ozturk Unsal I. , Tutal Akkaya E. , Ucan B. , Cakal E. , Gultuna Ozguclu S. , Ozbek M. , Sahin M. , Topaloglu O. , Delibasi T.

Objective: Nesfatin-1, was recently discovered in the brain which is derived from nucleobindin2 (NUCB2). Central and peripheral administration of nesfatin-1, inhibits food intake, dose-dependently. Hyperthyroid patients have increased appetite and food intake with a craving for carbohydrate-rich food, at the beginning of disease, but the physiological mechanisms underlying this behavior is not known exactly. In this study, we investigated whether nesfatin-1 is involved in the ...